Currently, the share price for Clinitech Laboratory Ltd. is delayed. Login to view live prices.
Clinitech Laboratory Ltd.
₹66.42
BSE
-- ( -- %) 1D
Income Statement
Also called a Profit & Loss statement, an Income Statement shows how a company has performed financially over a specific accounting period. It focuses on revenue, expenses, profits, and losses.
Particulars (In Cr) | Mar 2024 | Y/Y Change |
---|---|---|
Operating Revenue | 6.40 | +0.79% |
Other Income | 0.04 | +100.00% |
Total Income | 6.44 | +1.26% |
Total Expenditure | 5.93 | +7.82% |
EBIDT | -- | |
Depreciation | 0.44 | -2.22% |
Interest | 0.07 | +16.67% |
Tax | 0.13 | -48.00% |
Net Profit | 0.37 | -39.34% |
Balance Sheet
A financial statement that provides details about a company’s assets, liabilities, and shareholders’ equity at a given point in time.
Particulars (In Cr) | Mar 2024 | Y/Y Change |
---|---|---|
Total Current Assets | 2.71 | +38.27% |
Total Non-Current Assets | 2.90 | -28.75% |
Fixed assets | 2.66 | +40.74% |
Total assets | 5.61 | -6.97% |
Total Current Liabilities | 1.63 | -7.39% |
Total Non-Current Liabilities | 0.43 | -77.37% |
Total Capital Plus Liabilities | 5.61 | -6.97% |
Total Shareholder Funds | 3.55 | +49.16% |
Total Debt to Equity | 0.24 | -44.19% |
Cash Flow
The net amount of cash or cash equivalents being transferred in and out of a company for a specified period of time. Cashflow stems from operating, investing and financing activities.
Particulars (In Cr) | Mar 2024 | Y/Y Change |
---|---|---|
Cash from Operating Activity | -1.40 | -212.00% |
Cash from Financing Activities | 0.56 | +522.22% |
Cash from Investing Activities | 0.75 | -215.38% |
Net Cash Flow | -0.08 | -111.76% |
Trademarks owned by their respective owners and shown here only for ease of recall of the respective owner by public.Disclaimer